Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-151,200
Closed -$2.61M 7927
2020
Q1
$2.61M Buy
151,200
+106,900
+241% +$2.73M ﹤0.01% 2508
2019
Q4
$1.35M Sell
44,300
-83,400
-65% -$2.46M ﹤0.01% 3936
2019
Q3
$3.85M Buy
+127,700
New +$3.77M ﹤0.01% 2627
2018
Q2
Sell
-204,800
Closed -$6.18M 7969
2018
Q1
$6.18M Sell
204,800
-295,300
-59% -$9.23M ﹤0.01% 2115
2017
Q4
$16.2M Buy
+500,100
New +$15.8M 0.01% 1338

Other funds holding AXTA

UBS Group's AXTA Position: Q1 2026 in Review

UBS Group increased its Axalta (AXTA) stake by 51% in Q1 2026, buying an estimated $47.2M and bringing the position to 4,389,796 shares worth $122M. The position accounts for 0.02% of the portfolio, ranked #914.

UBS Group first reported a position in AXTA in Q4 2014 and has held it in 46 quarters since. 381 funds tracked by Wall St. Rank hold AXTA as of Q1 2026.

  • UBS Group held 4,389,796 shares of Axalta worth $122M as of Q1 2026.
  • UBS Group bought 1,487,289 Axalta shares in Q1 2026, an estimated $47.2M.
  • Axalta made up 0.02% of UBS Group's portfolio in Q1 2026, its #914 holding.
  • UBS Group first reported a position in Axalta in Q4 2014 and has held it in 46 quarters since.
  • 381 funds tracked by Wall St. Rank held Axalta as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.